Equity Research Services-Skilled Nursing Care Facilities

Should You Buy National HealthCare Corporation Stock in 2026?

By CirclFi Research Team · · 12/13 models active

According to the CirclFi Deep Alpha Valuation Engine, National HealthCare Corporation (NHC) presents a moderate quality profile with a QOC score of 5.3/10. Trading at $220.34, separating genuine undervalued opportunities from value traps is essential, as detailed by our model data.

The short answer: 2 of 12 CirclFi valuation models project upside for National HealthCare Corporation (NHC) at $220.34 — the model consensus leans bearish, with a Quality Score of 5.3/10 and Value-Trap risk of 25/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 10 of 12 models suggest overvaluation — majority bearish
  • Quality Score: 5.3/10 — Moderate — mixed signals
  • Value Trap Risk: 25/100 — Low — manageable risk
  • Fair Value Range: $8.21 – $246.54 (2902% spread)

Bullish Models

2 / 12

Bearish Models

10 / 12

Quality Score

5.3 /10

Moderate — mixed signals

Value Trap Risk

25 /100
Low

Low — manageable risk

Model Consensus

12 /13
Active Models

Avg. confidence: 44%

Investment Thesis

The Bull Case

Target: $246.54 (+11.9% upside)

The Bear Case

Target: $8.21 (-96.3%)

  • According to the CirclFi Quality of Company (QOC) framework, National HealthCare Corporation's rating of 5.3/10 indicates below-average quality, raising questions about sustainable earnings levels.
  • According to the CirclFi Deep Alpha Valuation Engine, the Bayesian DCF model sees the stock as overvalued with a fair value of $8.21 (-96.3%), suggesting that the market price embeds overly optimistic growth assumptions.
  • According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +108.2% spread between the most bullish and bearish models, signaling elevated analytical uncertainty.

Peer Benchmarking

ENSG The Ensign Group, In
9.3
PACS PACS Group, Inc.
8.3

Valuation Divergence

Spread

2902%

Fair Value Range

$8.21 – $246.54

A 2902% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

ML-RIV

$246.54 (+11.9%)

Most Bearish

Bayesian DCF

$8.21 (-96.3%)

Key Risk Factors

Model Disagreement

2902% spread signals high variance in projections.

Bearish Consensus

10/12 models suggest overvaluation.

Macro/Sector Risk

Services-Skilled Nursing Care Facilities headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View NHC Data Page →

The Bottom Line

Our valuation engine sends a clear cautionary signal on National HealthCare Corporation at $220.34. 10/12 models flag overvaluation, composite fair value sits at $112.80 (-48.8%), and the risk-reward profile appears unfavorable. Quality at 5.3/10 adds to the concern. This is a stock where patience — or avoidance — may be the optimal strategy.

These are quantitative model outputs, not investment recommendations. National HealthCare Corporation's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

Frequently Asked Questions

Should I buy NHC stock right now?

Based on CirclFi's multi-model analysis, 2 of 12 models see upside for NHC at $220.34. The models are divided, which means the investment case depends heavily on your assumptions about National HealthCare Corporation's future. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in National HealthCare Corporation?

Key risks include: wide model disagreement (2902% spread), signaling high uncertainty; general market and sector-specific risks affecting Services-Skilled Nursing Care Facilities companies. Always diversify and consult a financial advisor.

How does NHC compare to its competitors?

Among Services-Skilled Nursing Care Facilities peers, NHC holds a Quality Score of 5.3/10. Comparable companies include ENSG (QOC 9.3), PACS (QOC 8.3). The relative ranking helps investors identify whether NHC offers better fundamental quality than alternatives in the same sector.

Is NHC a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. NHC's Quality Score of 5.3/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.

What price should I buy NHC at?

CirclFi does not provide target buy prices or price alerts. However, our 12 active models produce fair value estimates ranging from $8.21 to $246.54. At $220.34, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for NHC.

View NHC Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →